FEOSPAN SPANSULE

Valsts: Īrija

Valoda: angļu

Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)

Nopērc to tagad

Lejuplādēt Produkta apraksts (SPC)
30-05-2014

Aktīvā sastāvdaļa:

FERROUS SULFATE EXSICCATED

Pieejams no:

Intrapharm Laboratories Limited

ATĶ kods:

B03AA07

SNN (starptautisko nepatentēto nosaukumu):

FERROUS SULFATE EXSICCATED

Deva:

150 Milligram

Zāļu forma:

Capsules Modified Release

Receptes veids:

Product not subject to medical prescription

Ārstniecības joma:

ferrous sulfate

Autorizācija statuss:

Not Marketed

Autorizācija datums:

1980-04-01

Produkta apraksts

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Feospan Spansule 150 mg Modified Release Capsules
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each modified release capsule contains 150 mg dried ferrous sulphate
(equivalent to 47 mg elemental iron).
Excipents: also contains sucrose 105.9 mg per capsule and sunset
yellow (E110).
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Modified release, hard capsule.
Modified release capsule containing red and green pellets in size no.
2 hard gelatin shells with clear bodies and ruby
red caps.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
In the prevention of iron deficiency anaemia in adults at risk.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults and children over 12 years:_
Two capsules per day.
_Elderly:_
Dosage as above.
_Children aged under 12 years:_
Not recommended.
Method of Administration
Oral.
Alternatively the capsule may be opened and the pellets mixed with
soft cold food but they must not be chewed or
sucked.
Medical advice should be sought if symptoms do not improve after four
weeks of use of this product as these symptoms
may reflect an underlying disease process.
4.3 CONTRAINDICATIONS
Do not use in patients with a known hypersensitivity to the active
ingredient.
Individuals with haemochromatosis and iron overload syndrome.
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_4_
_/_
_0_
_9_
_/_
_2_
_0_
_1_
_2_
_C_
_R_
_N_
_ _
_2_
_0_
_8_
_3_
_5_
_9_
_8_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
                                
                                Izlasiet visu dokumentu
                                
                            

Meklēt brīdinājumus, kas saistīti ar šo produktu

Skatīt dokumentu vēsturi